P148 Solriamfetol Titration & AdministRaTion (START): Dosing and titration strategies in patients with narcolepsy starting solriamfetol

INTRODUCTION: Solriamfetol (Sunosi) is a dopamine/norepinephrine reuptake inhibitor approved (EU/US) to treat excessive daytime sleepiness (EDS) in adults with narcolepsy (75–150 mg/day) or obstructive sleep apnoea (OSA) (37.5–150 mg/day). This study characterised real-world dosing and titration wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorpy, M, Hyman, D, Parks, G, Chen, A, Foley, C, Ito, D, Singh, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108998/
http://dx.doi.org/10.1093/sleepadvances/zpab014.189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108998/
http://dx.doi.org/10.1093/sleepadvances/zpab014.189

Ejemplares similares